Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY-NC-NDClinical epigenetics

Promoter CpG island hypomethylation and overexpression of molecules homologous to the muscle autoantigens acetylcholine receptor and ryanodine receptor in thymoma epithelial cells associated with myasthenia gravis.

5 affiliations
  1. 1Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China. [email protected].
  2. 2Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  3. 3Department of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  4. 4Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  5. 5Department of Neurology, Haukeland University Hospital, Bergen, Norway.

Abstract

Background

Thymoma-associated myasthenia gravis (TAMG) represents the paraneoplastic subtype of MG and is characterized by autoantibodies against skeletal muscle proteins, such as acetylcholine receptor (AChR), titin, and ryanodine receptor (RyR). Thymic epithelial cells of TAMG patients overexpress neuronal and neuromuscular genes that code for MG autoantigen epitopes. This may contribute to the autoimmune breakdown in TAMG patients. This study explored whether such aberrant expression of autoimmune epitopes is regulated by their promoter CpG methylation profiles.Methods

The thymoma bulk RNA sequencing, single cell RNA sequencing, and DNA methylation data were collected from 40 TAMG and 96 non-MG thymoma patients using three independent cohorts. A novel algorithm using a multiple linear regression model was developed to examine the gene promoter CpG island methylation status in TAMG and non-thymoma MG patients. The correlation between promoter CpG island and RNA expression in the TAMG thymoma was explored.Results

In both TAMG and non-MG thymoma, the global promoter CpG islands were hypomethylated and were negatively correlated with RNA expression. The CpG islands at promoters of muscle-like epitope genes, NEFM and RYR3, were significantly hypomethylated in TAMG thymoma and negatively correlated with mRNA expression in both a primary and a verification cohort. For MG antigen genes CHRNA1, TTN and RyR1, the CHRNA1 promoter CpG site methylation correlated negatively with CHRNA1 RNA expression. However, there was no difference in promoter methylation status between TAMG and non-MG thymomas. For the AIRE gene, the promoter CPG islands were significantly hypermethylated and negatively correlated with mRNA expression. Both bulk and single cell RNA sequencing showed that key genes involved in the DNA CpG methylation pathways, including DNMT1, UHRF1 and HDAC1, had a reduced expression in thymic epithelial cells of TAMG thymoma.Conclusions

Our results indicate that the aberrant overexpression of muscle-like epitopes in TAMG might be driven by CpG island hypomethylation. This represents a novel mechanism for intrathymic autoantigen regulation, relevant for the early pathogenesis of TAMG and thymoma-associated autoimmune disorders. Our findings should be verified in larger cohorts and with functional and histological validation.

Related

  1. P-cadherin Overexpression Induces Partial Epithelial-to-Mesenchymal Transition and Confers Chemoresistance in Dysplastic Oral Epithelial Cells.
    Aaron Suresh Mody, Christine Paulette Neal, Kristen Kim Drinkwater +2
    Journal of CancerPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Mimicking FUS hypomethylation preferentially weakens excitatory synapses via AMPA and NMDA-receptor dysregulation
    Margarita Toneva, Fanbo Kong, Siwon Oh +4
    Scientific ReportsPeer-reviewedCC BY 4.0Full textNeurologyCrossref
  3. Promoter hypomethylation associated with elevated TRIM33 expression in triple-negative breast cancer patients
    Archana Chaudhary, Manish Kumar, Md. Jawed Akhtar +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  4. Acetylcholine Provocation Testing for Coronary Vasomotor Disorders
    Andrea Caffè, Francesco M. Animati, Rocco A. Montone
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Alternative Splicing of Homologous Recombination Genes Is Associated with Homologous Recombination Deficiency and Immunoregulatory Phenotypes in Breast Cancer
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{hong2026promoter,
  title = {{Promoter CpG island hypomethylation and overexpression of molecules homologous to the muscle autoantigens acetylcholine receptor and ryanodine receptor in thymoma epithelial cells associated with myasthenia gravis.}},
  author = {Yu Hong and Hai-Feng Li and Yanjun Guo and Lei Liu and Geir Olve Skeie and Jiawei Wang and Nils Erik Gilhus},
  journal = {Clinical epigenetics},
  year = {2026},
  month = aug,
  doi = {10.1186/s13148-026-02213-x},
  url = {https://europepmc.org/article/MED/42972561},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Promoter CpG island hypomethylation and overexpression of molecules homologous to the muscle autoantigens acetylcholine receptor and ryanodine receptor in thymoma epithelial cells associated with myasthenia gravis.
AU  - Yu Hong
AU  - Hai-Feng Li
AU  - Yanjun Guo
AU  - Lei Liu
AU  - Geir Olve Skeie
AU  - Jiawei Wang
AU  - Nils Erik Gilhus
PY  - 2026
DA  - 2026/08/04
JO  - Clinical epigenetics
DO  - 10.1186/s13148-026-02213-x
UR  - https://europepmc.org/article/MED/42972561
AB  - Background  Thymoma-associated myasthenia gravis (TAMG) represents the paraneoplastic subtype of MG and is characterized by autoantibodies against skeletal muscle proteins, such as acetylcholine receptor (AChR), titin, and ryanodine receptor (RyR). Thymic epithelial cells of TAMG patients overexpress neuronal and neuromuscular genes that code for MG autoantigen epitopes. This may contribute to the autoimmune breakdown in TAMG patients. This study explored whether such aberrant expression of autoimmune epitopes is regulated by their promoter CpG methylation profiles.Methods  The thymoma bulk RNA sequencing, single cell RNA sequencing, and DNA methylation data were collected from 40 TAMG and 96 non-MG thymoma patients using three independent cohorts. A novel algorithm using a multiple linear regression model was developed to examine the gene promoter CpG island methylation status in TAMG and non-thymoma MG patients. The correlation between promoter CpG island and RNA expression in the TAMG thymoma was explored.Results  In both TAMG and non-MG thymoma, the global promoter CpG islands were hypomethylated and were negatively correlated with RNA expression. The CpG islands at promoters of muscle-like epitope genes, NEFM and RYR3, were significantly hypomethylated in TAMG thymoma and negatively correlated with mRNA expression in both a primary and a verification cohort. For MG antigen genes CHRNA1, TTN and RyR1, the CHRNA1 promoter CpG site methylation correlated negatively with CHRNA1 RNA expression. However, there was no difference in promoter methylation status between TAMG and non-MG thymomas. For the AIRE gene, the promoter CPG islands were significantly hypermethylated and negatively correlated with mRNA expression. Both bulk and single cell RNA sequencing showed that key genes involved in the DNA CpG methylation pathways, including DNMT1, UHRF1 and HDAC1, had a reduced expression in thymic epithelial cells of TAMG thymoma.Conclusions  Our results indicate that the aberrant overexpression of muscle-like epitopes in TAMG might be driven by CpG island hypomethylation. This represents a novel mechanism for intrathymic autoantigen regulation, relevant for the early pathogenesis of TAMG and thymoma-associated autoimmune disorders. Our findings should be verified in larger cohorts and with functional and histological validation.
SN  - 1868-7083
SN  - 1868-7075
ER  -